MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Kips Bay losses more than triple
Kips Bay Medical Inc. (NSDQ:KIPS) reported losses of $803,000, or 6 cents per diluted share, on sales of $116,000 during the three months ended Dec. 31, 2010. That compares with losses $117,000, or 1 cent per diluted share, on no revenues during the same period in 2009.
Full-year losses were $10.9 million, or 81 cents per share, on sales of $223,000. That compares with losses of $3.3 million, or 30 cents per share, on no revenues in 2009.
Read more
Cytomedix reports 2010 results in preparation for public offering
Cytomedix Inc. (OTC:CMXI) reported a net loss of $9.0 million, or 23 cents per diluted share, on sales of $3.9 million for the year ended Dec. 31, 2010.
Read more
Medicago commences sales, losses widen
Medicago Inc. (TSX:MDG) reported losses of $4.8 million ($4.6 million CAD) on sales of $77,882 ($75,000 CAD) during the three months ended Dec. 31, 2010. That compares with losses of $4.0 million ($3.9 million CAD), or 4 cents (4 cents CAD) per basic share, on no revenues during the same period in 2009.
Full-year losses were $16.9 million ($16.3 million CAD) million, or 13 cents (13 cents CAD) per share, on sales of $113,188 ($109,000 CAD). That compares with losses of $13.0 million ($12.5 million CAD), or 13 cents (13 cents CAD) per share, on no sales in 2009. Figures based on latest exchange rates.
Read more
Lumenis sales rise 5 percent, profits more than double
Lumenis Ltd. reported profits of $5.7 million, or 3 cents per diluted share, on sales of $237.7 million for the year ended Dec. 31, 2010. That compares with profits of $2.7 million, or 1 cent per diluted share, on sales of $226.1 million in 2009.
Read more
Fibrocell reports results for 2010
Fibrocell Science Inc. (OTC:FCSC) reported losses of $12.9 million, or 68 cents per share, on sales of $936,369 for the year ended Dec. 31, 2010.
Read more
China Biologic profits increase 189 percent
China Biologic Products Inc. (NSDQ:CBPO) reported profits of $52.0 million, or $1.30 per diluted share, on sales of $139.7 million for the year ended Dec. 31, 2010. That compares with profits $18.8 million, or 10 cents per diluted share, on sales of $119.0 million in 2009.
Read more
